Drug intelligence / Profile preview

Zyflamend

Development stage
Unknown
Lead developer
NewChapter
Administration
Oral
01

Overview

Zyflamend is a proprietary, multi-herbal dietary supplement developed for pain relief, joint support, and to promote a healthy inflammation response. It is formulated as a blend of ten botanical extracts—rosemary, turmeric, ginger, holy basil, green tea, hu zhang, Chinese goldthread, barberry, oregano, and Chinese skullcap. Laboratory studies suggest Zyflamend ingredients possess anti-inflammatory, antiangiogenic, and antiproliferative properties, including inhibition of COX-2 and NF-kappa B pathways. Limited human studies indicate reduction in inflammatory biomarkers (such as C-reactive protein and NF-kappa B levels) and safety in phase I prostate-related clinical trials. The product is marketed as supporting joint function, mobility, flexibility, and general inflammation balance.

Brand names
Zyflamend
Other names
Zyflammend Whole Body
02

Targets

CYP19A1 (Aromatase)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)HDAC (HDAC family)NF-κB

Beyond the preview

Go deeper on Zyflamend.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zyflamend.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call